Amoebic keratitis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:67043B60.1+H19.2*
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Amoebic keratitis, also known as Acanthamoeba keratitis (AK), is a rare but serious infection of the cornea (the clear front surface of the eye) caused by free-living amoebae of the genus Acanthamoeba. These microscopic organisms are ubiquitous in the environment, found in soil, freshwater, and even tap water. The infection predominantly affects the eye, specifically the corneal epithelium and stroma, and can lead to severe pain, photophobia (sensitivity to light), excessive tearing, blurred vision, and a characteristic ring-shaped corneal infiltrate. The condition is strongly associated with contact lens wear, particularly when lenses are exposed to contaminated water or improperly cleaned. Other risk factors include corneal trauma and exposure to contaminated water sources. The disease can be difficult to diagnose early because its symptoms often mimic those of other forms of infectious keratitis, such as herpes simplex keratitis or bacterial keratitis. Delayed diagnosis frequently leads to worse outcomes. Diagnosis is typically confirmed through corneal scraping with culture on non-nutrient agar seeded with bacteria, confocal microscopy, or polymerase chain reaction (PCR) testing. If left untreated or inadequately treated, Acanthamoeba keratitis can progress to corneal ulceration, perforation, and potentially permanent vision loss. Treatment is prolonged and challenging, typically involving a combination of topical antiseptic agents such as polyhexamethylene biguanide (PHMB) or chlorhexidine, often combined with a diamidine such as propamidine isethionate (Brolene). Treatment courses frequently last several months due to the organism's ability to form resistant cysts. In severe or refractory cases, corneal transplantation (penetrating keratoplasty) may be necessary. Early diagnosis and prompt initiation of appropriate antimicrobial therapy are critical for preserving vision. Prevention strategies focus on proper contact lens hygiene and avoiding exposure of lenses to water.

Clinical phenotype terms— hover any for plain English:

Abnormal cornea morphologyHP:0000481Punctate opacification of the corneaHP:0007856Abnormal corneal epithelium morphologyHP:0011495Iris atrophyHP:0001089Abnormal posterior eye segment morphologyHP:0004329Anterior uveitisHP:0012122Decreased corneal sensationHP:0012155ScleritisHP:0100532Corneal perforationHP:0100583Abnormal anterior chamber morphologyHP:0000593Corneal stromal edemaHP:0012040Corneal ulcerationHP:0012804
Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Amoebic keratitis.

View clinical trials →

No actively recruiting trials found for Amoebic keratitis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Amoebic keratitis community →

No specialists are currently listed for Amoebic keratitis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Amoebic keratitis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Amoebic keratitisForum →

No community posts yet. Be the first to share your experience with Amoebic keratitis.

Start the conversation →

Latest news about Amoebic keratitis

No recent news articles for Amoebic keratitis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Amoebic keratitis

What is Amoebic keratitis?

Amoebic keratitis, also known as Acanthamoeba keratitis (AK), is a rare but serious infection of the cornea (the clear front surface of the eye) caused by free-living amoebae of the genus Acanthamoeba. These microscopic organisms are ubiquitous in the environment, found in soil, freshwater, and even tap water. The infection predominantly affects the eye, specifically the corneal epithelium and stroma, and can lead to severe pain, photophobia (sensitivity to light), excessive tearing, blurred vision, and a characteristic ring-shaped corneal infiltrate. The condition is strongly associated with